Key result
Expert panel outlines current diagnostic, mechanistic, and therapeutic approaches for vascular dementia.
Answers are grounded in this paper and cite their sources.
This expert panel review provides a critical appraisal of the epidemiology, pathobiology, and management of vascular cognitive impairment and dementia.
Cognitive impairment associated with aging has emerged as one of the major public health challenges of our time. Although Alzheimer’s disease is the leading cause of clinically diagnosed dementia in Western countries, cognitive impairment of vascular etiology is the second most common cause and may be the predominant one in East Asia. Furthermore, alterations of the large and small cerebral vasculature, including those affecting the microcirculation of the subcortical white matter, are key contributors to the clinical expression of cognitive dysfunction caused by other pathologies, including Alzheimer’s disease. This scientific expert panel provides a critical appraisal of the epidemiology, pathobiology, neuropathology, and neuroimaging of vascular cognitive impairment and dementia, and of current diagnostic and therapeutic approaches. Unresolved issues are also examined to shed light on new basic and clinical research avenues that may lead to mitigating one of the most devastating human conditions.
No takes yet. Share an insight, caveat, or question.
Iadecola et al. (2019) conducted a review in Vascular Cognitive Impairment and Dementia. This scientific expert panel provides a critical appraisal of the epidemiology, pathobiology, neuropathology, neuroimaging, and current diagnostic and therapeutic approaches for vascular dementia.
Synapse has enriched 10 related papers. Consider them for comparative context: